抗CD20单克隆抗体
Search documents
TG Therapeutics (NasdaqCM:TGTX) FY Conference Transcript
2026-01-13 22:32
TG Therapeutics (NasdaqCM:TGTX) FY Conference January 13, 2026 04:30 PM ET Company ParticipantsMichael Weiss - CEOConference Call ParticipantsBrian Cheng - Senior Biotech AnalystBrian ChengGood afternoon, everyone. Thanks for joining us for another session at the 44th J.P. Morgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have Mike Weiss, who is the CEO of TG Therapeutics. I'll now pass the mic to their CEO for a short presentation, followed ...